^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AFM11

    i
    Other names: AFM11, AFM11 TandAb, CD19 x CD3 TandAb
    Associations

    News

    Trials
    Company:
    Affimed
    Drug class:
    CD3 agonist, CD19 inhibitor
    Related drugs:
    Associations

    News

    Trials
    almost2years
    Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies. (PubMed, Trials)
    AFM11 treatment was associated with frequent neurological adverse reactions that were severe in some patients. In ALL, some signs of activity, albeit short-lived, were observed whereas no activity was observed in patients with NHL; therefore, further clinical development was terminated.
    P1 data • Journal
    |
    CD19 (CD19 Molecule)
    |
    CD19 positive
    |
    AFM11